BLGO: CODE KENNETH REAY discloses securities transactions
By AlphaYouPublished Form 4
CODE KENNETH REAY
Reporting filer
CODE KENNETH REAY reported Grant or award in BIOLARGO, INC.: 566261 units of Common Stock, dated 2026-09-30. The full Form 4 contains 2 transaction entries.
- Disclosed
- Oct 2, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | CODE KENNETH REAY | 2026-09-30 | A | Grant or award | 566261 | 0.08 | 26,974,580 | 2 days | Filed terms
|
| Common Stock | CODE KENNETH REAY | 2026-09-30 | G | Gift | 2000000 | 0 | 24,974,580 | 2 days | Filed terms
|
Common Stock
- Owner
- CODE KENNETH REAY
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 566261
- Price
- 0.08
- Following holdings
- 26,974,580
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 566261
- id: F1
- transaction Price Per Share: 0.08
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 26974580
- id: F3
- direct Or Indirect Ownership: D
Common Stock
- Owner
- CODE KENNETH REAY
- Date
- 2026-09-30
- Code
- G
- Action
- Gift
- Quantity
- 2000000
- Price
- 0
- Following holdings
- 24,974,580
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: G
- equity Swap Involved: 0
- transaction Shares: 2000000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 24974580
- id: F3
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- CODE KENNETH REAY: Chief Science Officer, Director.
- F1: The shares acquired are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer.
- F2: Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares acquired and the acquisition price per share).
- F3: Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.
Original sources
Prepared automatically from public filing data. Report a correction.